Close
Close
Treatment Database
itolizumab
Trade Name not avaiable
Orphan Indication Prevention of acute graft versus host disease
USA Market Approval
USA Designation Date 05-02-2019
Sponsor Equillium, Inc.
2223 Avenida De La Playa, Suite 108
San Diego, California, 92037
More about Graft Versus Host Disease
Free Newsletter
Related Videos
by Abidemi Uruejoma
6,030 views
by Salima Mathews
9,620 views